MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Genetic landscape of dystonia in Asian Indian patients

    R. Rajan, A. Saini, R. Mewara, B. Verma, D. Radhakrishnan, E. Arunmozhimaran, A. Gupta, V. Vishnu, M. Singh, R. Bhatia, R. Mir, I. Singh, F. Mohammed, B. Binukumar, V. Scaria, A. Srivastava, P. Srivastava (New Delhi, India)

    Objective: To identify potentially pathogenic genomic variations associated with dystonia phenotypes in Asian Indian patients with dystonia. Background: The Asian Indian population is underrepresented in…
  • 2022 International Congress

    Comparison of Disease Progression in Patients with Brain-first versus Body-first Parkinson’s Disease

    DW. Ryu, SW. Yoo, KS. Lee, SG. Ha, JS. Kim (Seoul, Republic of Korea)

    Objective: This study aimed to compare the clinical progression between brain-first and body-first PD groups using cardiac sympathetic denervation (CSD). Background: Brain-first and body-first Parkinson’s…
  • 2022 International Congress

    Developing New Insights Into Clinical and Genetic Features of PD – The Global Parkinson’s Genetics Program (GP2) Clinical Cohorts Working Group

    M. Richer, C. Towns, A. Martinez-Carrasco, J. Solle, A. Singleton, C. Blauwendraat, M. Tan, H. Iwaki, D. Vitale, Y. Song, M. Nalls, T. Antar, H. Morris (London, United Kingdom)

    Objective: We aim to recruit Parkinson’s cohorts across the world for the Global Parkinson’s Genetics Program (GP2, http://gp2.org/), harmonize clinical data for joint analysis and…
  • 2022 International Congress

    The relationship of non-motor symptoms in Parkinson’s disease

    E. Golchenko, Y. Karakulova (Perm, Russian Federation)

    Objective:  Evaluation of non-motor symptoms in patients with Parkinson's disease, evaluation of the relationship of autonomic and neuropsychiatric disorders. Background: This work included a comprehensive…
  • 2022 International Congress

    Protective mechanism of melatonin via heat shock protein in the MPP+-induced in vitro Parkinson’s disease model

    YJ. Jung, E. Oh, A. Kim, H. Choi (Daejeon, Republic of Korea)

    Objective: The objective of this study was to investigate the protective properties of melatonin in an in vitro Parkinson’s disease (PD) model, especially focusing on…
  • 2022 International Congress

    Cortical and cerebellar excitability in essential tremor

    C. Ammann, C. Pagge, JA. Pineda-Pardo, M. Del álamo, R. Martínez-Fernández, A. Oliviero, JA. Obeso, G. Foffani (Móstoles, Spain)

    Objective: To investigate the functional state of motor cortex excitability and the involvement of the cerebello-thalamo-cortical pathway using transcranial magnetic stimulation (TMS) in patients with…
  • 2022 International Congress

    Type 2 diabetes-associated transcriptomic changes in Parkinson’s disease and non-neurodegenerative control brains.

    P. Cullinane, E. de Pablo-Fernandez, K. Ebanks, Z. Jaunmuktane, T. Warner (London, United Kingdom)

    Objective: To evaluate the effect of type 2 diabetes (T2D) on gene transcription in Parkinson’s disease (PD) and non-neurodegenerative control brains. Background: People with T2D…
  • 2022 International Congress

    Unilateral Hypertrophic Olivary Degeneration in Anti-GAD-associated Encephalomyelitis

    O. Turgunkhujaev, YU. Seliverstov, V. Fominykh, L. Brylev (Moscow, Russian Federation)

    Objective: We present a patient with GAD65-Ab-related encephalomyelitis who developed unilateral hypertrophic olivary degeneration (HOD) in the absence of structural lesions within the Guillain-Mollaret triangle.…
  • 2022 International Congress

    How much do motor and non-motor symptoms of Huntington’s disease influence energy balance? BEHD-EM Pilot Study.

    C. Collazo, E. Cubo, L. Simón, J. Rivadeneyra, A. Rodríguez, J. Raya, D. Castillo, M. Soto (Burgos, Spain)

    Objective: To study energy balance (EB) in patients with Huntington's disease (HD) and compare it with healthy controls; to study the impact of EB on…
  • 2022 International Congress

    Chronic Visceral Pain in Parkinson’s Disease and Link with White Matter Hyperintensities

    K. Rukavina, J. Staunton, M. Krbot Skoric, S. Rota, A. Rizos, K. Ray Chaudhuri (London, United Kingdom)

    Objective: To explore whether there is a link between chronic visceral pain and white matter hyperintensities (WMH) on brain magnetic resonance imaging (MRI) in People…
  • « Previous Page
  • 1
  • …
  • 566
  • 567
  • 568
  • 569
  • 570
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley